company background image

YIACO Medical Company K.S.C.P KWSE:YIACO Stock Report

Last Price


Market Cap







24 Sep, 2022


Company Financials
YIACO fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance0/6
Financial Health4/6

YIACO Stock Overview

YIACO Medical Company K.S.C.P., together with its subsidiaries, sells medicines, healthcare related products, medical equipment, and dental equipment and materials in Kuwait.

YIACO Medical Company K.S.C.P Competitors

Price History & Performance

Summary of all time highs, changes and price drops for YIACO Medical Company K.S.C.P
Historical stock prices
Current Share Priceد.ك0.45
52 Week Highد.ك0.48
52 Week Lowد.ك0.40
1 Month Change0%
3 Month Change0%
1 Year Change2.27%
3 Year Change-36.32%
5 Year Change-75.80%
Change since IPO-78.24%

Recent News & Updates

Shareholder Returns

YIACOKW HealthcareKW Market

Return vs Industry: YIACO exceeded the KW Healthcare industry which returned -24.1% over the past year.

Return vs Market: YIACO underperformed the KW Market which returned 7.2% over the past year.

Price Volatility

Is YIACO's price volatile compared to industry and market?
YIACO volatility
YIACO Average Weekly Movement0%
Healthcare Industry Average Movement4.8%
Market Average Movement4.9%
10% most volatile stocks in KW Market9.5%
10% least volatile stocks in KW Market2.3%

Stable Share Price: YIACO is less volatile than 75% of KW stocks over the past 3 months, typically moving +/- 0% a week.

Volatility Over Time: YIACO's weekly volatility (0%) has been stable over the past year.

About the Company

1953n/aSheikh Ahmad Salem Al Al Sabah

YIACO Medical Company K.S.C.P., together with its subsidiaries, sells medicines, healthcare related products, medical equipment, and dental equipment and materials in Kuwait. It supplies pharmaceutical and consumer health care products; veterinary, agricultural, and public health products; skincare products; hospital, laboratory, scientific, and dental equipment and materials; hospital furniture, physiotherapy, rehabilitation, home health care, diagnostics and evaluation, respiratory, and manikins and simulator products; and sports medicine, customized prescribed wheelchairs, and adult rehabilitations. The company also owns and manages a chain of 31 retail pharmacies; operates a chain of medical diagnostic centers; and offers home care and outpatient health care services.

YIACO Medical Company K.S.C.P Fundamentals Summary

How do YIACO Medical Company K.S.C.P's earnings and revenue compare to its market cap?
YIACO fundamental statistics
Market Capد.ك7.70m
Earnings (TTM)-د.ك1.50m
Revenue (TTM)د.ك16.38m


P/S Ratio


P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
YIACO income statement (TTM)
Cost of Revenueد.ك10.02m
Gross Profitد.ك6.36m
Other Expensesد.ك7.86m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date


Earnings per share (EPS)-0.087
Gross Margin38.82%
Net Profit Margin-9.14%
Debt/Equity Ratio4,235.5%

How did YIACO perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.


Is YIACO undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score


Valuation Score 4/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for YIACO?

Other financial metrics that can be useful for relative valuation.

YIACO key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenuen/a
Enterprise Value/EBITDAn/a
PEG Ration/a

Price to Sales Ratio vs Peers

How does YIACO's PS Ratio compare to its peers?

YIACO PS Ratio vs Peers
The above table shows the PS ratio for YIACO vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average0.8x
ATC Advanced Technology Company K.S.C.P
TM Techno Medical
9265 Yamashita Health Care HoldingsInc
3118 Level Biotechnology
YIACO YIACO Medical Company K.S.C.P

Price-To-Sales vs Peers: YIACO is good value based on its Price-To-Sales Ratio (0.5x) compared to the peer average (0.8x).

Price to Earnings Ratio vs Industry

How does YIACO's PE Ratio compare vs other companies in the Asian Healthcare Industry?

Price-To-Sales vs Industry: YIACO is good value based on its Price-To-Sales Ratio (0.5x) compared to the Asian Healthcare industry average (1.7x)

Price to Sales Ratio vs Fair Ratio

What is YIACO's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

YIACO PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.5x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate YIACO's Price-To-Sales Fair Ratio for valuation analysis.

Share Price vs Fair Value

What is the Fair Price of YIACO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: YIACO (KWD0.45) is trading below our estimate of fair value (KWD0.76)

Significantly Below Fair Value: YIACO is trading below fair value by more than 20%.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Future Growth

How is YIACO Medical Company K.S.C.P forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score


Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as YIACO Medical Company K.S.C.P has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Discover growth companies

  • Examine whether YIACO Medical Company K.S.C.P is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.

Past Performance

How has YIACO Medical Company K.S.C.P performed over the past 5 years?

Past Performance Score


Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: YIACO is currently unprofitable.

Growing Profit Margin: YIACO is currently unprofitable.

Past Earnings Growth Analysis

Earnings Trend: YIACO is unprofitable, but has reduced losses over the past 5 years at a rate of 46.4% per year.

Accelerating Growth: Unable to compare YIACO's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: YIACO is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (15.5%).

Return on Equity

High ROE: YIACO has a negative Return on Equity (-845.53%), as it is currently unprofitable.

Discover strong past performing companies

Financial Health

How is YIACO Medical Company K.S.C.P's financial position?

Financial Health Score


Financial Health Score 4/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: YIACO's short term assets (KWD24.0M) do not cover its short term liabilities (KWD31.3M).

Long Term Liabilities: YIACO's short term assets (KWD24.0M) exceed its long term liabilities (KWD1.4M).

Debt to Equity History and Analysis

Debt Level: YIACO has more cash than its total debt.

Reducing Debt: YIACO's debt to equity ratio has increased from 324.8% to 4235.5% over the past 5 years.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable YIACO has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: YIACO is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 25.9% per year.

Discover healthy companies


What is YIACO Medical Company K.S.C.P current dividend yield, its reliability and sustainability?

Dividend Score


Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate YIACO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate YIACO's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if YIACO's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if YIACO's dividend payments have been increasing.

Earnings Payout to Shareholders

Earnings Coverage: YIACO is not paying a notable dividend for the KW market.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as YIACO has not reported any payouts.

Discover strong dividend paying companies


How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


Sheikh Ahmad Salem Al Al Sabah



Mr. Sheikh Ahmad Salem Al Ali Al Sabah is Vice Chairman and CEO at YIACO Medical Company K.S.C.P. since April 2018.

Leadership Team

Experienced Management: YIACO's management team is seasoned and experienced (6.4 years average tenure).

Board Members

Experienced Board: YIACO's board of directors are considered experienced (3.2 years average tenure).


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 6 shareholders own 76.89% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
Kuwait Finance House K.S.C.P.
4,678,862KWD2.1m0%no data
Melas Investment Co
2,661,456KWD1.2m0%no data
Nasca Holdings Company Limited
2,635,605KWD1.2m0%no data
Khaleda Almakhld
1,530,859KWD688.9k0%no data
Zamzam AlHussain Rajab
828,602KWD372.9k0%no data
Habib Behbehani
828,602KWD372.9k0%no data

Company Information

YIACO Medical Company K.S.C.P's employee growth, exchange listings and data sources

Key Information

  • Name: YIACO Medical Company K.S.C.P
  • Ticker: YIACO
  • Exchange: KWSE
  • Founded: 1953
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Implied Market Cap: د.ك7.704m
  • Shares outstanding: 17.12m
  • Website:


  • YIACO Medical Company K.S.C.P
  • Sama Tower
  • Salmiya, Block No. 5
  • Kuwait City
  • 13005
  • Kuwait


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
YIACOKWSE (Kuwait Stock Exchange)YesShare CapitalKWKWDNov 2007

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/09/24 00:00
End of Day Share Price2022/09/22 00:00
Annual Earnings2021/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.